What is the long-term trend for Select Medical Holdings's debt instrument, fair value disclosure?

Over 5 years (2020 to 2025), Select Medical Holdings's debt instrument, fair value disclosure has grown at a -12.1% compound annual growth rate (CAGR), from $3.47B to $1.83B.

Select Medical Holdings SEM Debt Instrument, Fair Value Disclosure

Debt Instrument, Fair Value Disclosure at other companies

BlackstoneBX

$11.95B+6.6%

MSCIMSCI

$6.13B+44.7%

Apollo Global ManagementAPO

$13.47B+32.4%

LennarLEN

$4.11B+85.3%

KEE

Keel Infrastructure Corp. Common StockKEEL

$590.25M—

Arthur J. GallagherAJG

$12.18B—

Other financials

Income statement

See full

Revenue$1.4B+5.0%

Gross profit$175.5M-2.8%

Operating income$98.4M-12.7%

Net income$44.0M-22.4%

EPS (diluted)$0.35-20.5%

Balance sheet

See full

Cash & equivalents$25.7M-51.7%

Total debt$3.0B+7.5%

Total equity$1.8B+2.1%

Total assets$6.0B+6.1%

Cash flow

See full

Operating cash flow$37.9M+1,195%

CapEx$58.9M+12.5%

Free cash flow-$21.0M+62.3%

Valuation

See full

Market cap$2.05B-6.2%

Profitability

See full

Gross margin11.3%-0.5pp

Operating margin5.8%+0.8pp

Net margin2.4%-0.9pp

FCF margin2.8%-4.1pp

Returns & leverage

See full

Return on equity7.7%-3.6pp

Debt / equity1.7×+0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentFairValue.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Select Medical Holdings's debt instrument, fair value disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Select Medical Holdings's debt instrument, fair value disclosure?: Select Medical Holdings (SEM) reported debt instrument, fair value disclosure of $1.84B in Q1 2026.
How has Select Medical Holdings's debt instrument, fair value disclosure changed year-over-year?: Select Medical Holdings's debt instrument, fair value disclosure increased by 2.5% year-over-year, from $1.79B to $1.84B.
What is the long-term trend for Select Medical Holdings's debt instrument, fair value disclosure?: Over 5 years (2020 to 2025), Select Medical Holdings's debt instrument, fair value disclosure has grown at a -12.1% compound annual growth rate (CAGR), from $3.47B to $1.83B.